Vaccine Research Center names new director
"John Mascola is a visionary leader who brings a wealth of talents as a basic scientist, clinician, clinical trialist and administrator to the helm of the Vaccine Research Center," NIAID Director Anthony S. Fauci said. "In particular, his exemplary work on elucidating the protective role of antibodies against HIV has greatly influenced current vaccine design efforts. I am confident that Dr. Mascola will continue and even accelerate our momentum toward the development of novel, effective vaccines against infectious diseases."
Mascola will lead the VRC research program in the fight against HIV/AIDS, influenza and other global epidemics. Mascola served as deputy director and acting director of the VRC and was part of a team that developed two antibodies that proved to neutralize more than 90 percent of all known HIV strains.
"John is an innovative scientist and a great choice to lead the Vaccine Research Center," NIH Director Francis S. Collins said. "His expertise in vaccine development will undoubtedly help advance important research programs against infectious diseases such as HIV/AIDS and influenza."
Mascola is a fellow of the American College of physicians, a member of the Infectious Diseases Society of America and was elected to the American Society of Clinical Investigation and the Association of American Physicians.
"The Vaccine Research Center is a unique, state-of-the-art facility, with a complement of extraordinarily dedicated and talented scientists and staff," Mascola said. "I am honored to be selected as its new director. I look forward to expanding our basic research on immune responses to HIV and other infections and applying this knowledge to the development of strategies to prevent and treat human diseases."